Stay updated on Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2Fk7MMIVbiPFd2dQZqy_EwcDQsVyk.uncropped.jpg&w=3840&q=75)
Latest updates to the Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial page
- Check3 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.0%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.0%
- Check32 days agoNo Change Detected
- Check46 days agoChange DetectedThe website has been updated to version 2.10.0, adding 2 more study numbers and removing the previous version 2.9.7.SummaryDifference0.2%
- Check53 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.0%
- Check66 days agoChange DetectedThe value in the web page has been updated to correct an error in the publication details of the study, specifically the erratum information for the article in Gastric Cancer. The correction now includes the correct publication details for the erratum in Gastric Cancer, 2021 Nov;24(6):1341. This change ensures accurate reporting of the study publication information.SummaryDifference0.1%
- Check67 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.SummaryDifference0.0%
Stay in the know with updates to Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial page.